Targeting neurosteroidogenesis as therapy for PTSD

@inproceedings{Pinna2013TargetingNA,
  title={Targeting neurosteroidogenesis as therapy for PTSD},
  author={Graziano Pinna},
  booktitle={Front. Pharmacol.},
  year={2013}
}
Posttraumatic stress disorder (PTSD) is a severe condition resulting from exposure to traumatic events, such as combat situations, sexual assault, serious injury or the threat of death. Symptoms include disturbing recurring flashbacks, avoidance or numbing of memories of the event, and hyperarousal, which continue for more than a month after the traumatic event. Reduced cortical GABA (Kugaya et al., 2003) and cebrospinal fluid (CSF) allopregnanolone levels (Rasmusson et al., 2006) that… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Rosmarinic acid ameliorates PTSD-like symptoms in a rat model and promotes cell proliferation in the hippocampus.

Progress in neuro-psychopharmacology & biological psychiatry • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 55 references

Can the antidys

A. Guidotti, E. Costa
1998
View 11 Excerpts
Highly Influenced

The pharmacology of neurosteroidogenesis.

The Journal of steroid biochemistry and molecular biology • 1994
View 12 Excerpts
Highly Influenced

Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD).

The international journal of neuropsychopharmacology • 2012
View 1 Excerpt

Allopregnanolone and Snorfluoxetine decrease anxietylike behavior in a mouse model of anxiety / depression

S. M. Nin, L. A. Martinez, R. Thomas, M. Nelson, G. Pinna
Trabajos del Instituto Cajal • 2011
View 3 Excerpts

Similar Papers

Loading similar papers…